Signaturefd, LLC Dynavax Technologies Corp Transaction History

Signaturefd, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$13.09 - $14.98 $235 - $269	18 New	18 $0
Q3 2022 Nov 08, 2022	SELL	$9.93 - $17.44 $52,480 - $92,170	-5,285 Reduced 96.09%	215 $2,000
Q1 2022 May 02, 2022	BUY	$9.75 - $14.44 $53,205 - $78,799	5,457 Added 12690.7%	5,500 $60,000
Q4 2021 Jan 25, 2022	BUY	$13.17 - $20.94 $566 - $900	43 New	43 $1,000
Q3 2021 Oct 28, 2021	SELL	$9.16 - $19.83 $760 - $1,645	-83 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$7.25 - $10.99 $601 - $912	83 New	83 $1,000
Q2 2020 Jul 30, 2020	SELL	$2.94 - $9.1 $2,410 - $7,462	-820 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$2.27 - $6.2 $1,861 - $5,084	820 New	820 $3,000

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.